Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 54 of the 54 references it cites were found in a registry or an index; 18 of the 61 sources its claims cite were checked for support.
Abstract
Mitochondrial complex II is a tumor suppressor comprised of four subunits (SdhA, SdhB, SdhC, and SdhD). Mutations in any of these should disrupt complex II enzymatic activity, yet defects in SdhA produce bioenergetic deficiency while defects in SdhB, SdhC, or SdhD induce tumor formation. The mechanisms underlying these differences are not known. We show that the inhibition of distal subunits of complex II, either pharmacologically or via RNA interference of SdhB, increases normoxic reactive oxygen species (ROS) production, increases hypoxia-inducible factor alpha (HIF-alpha) stabilization in an ROS-dependent manner, and increases growth rates in vitro and in vivo without affecting hypoxia-mediated activation of HIF-alpha. Proximal pharmacologic inhibition or RNA interference of complex II at SdhA, however, does not increase normoxic ROS production or HIF-alpha stabilization and results in decreased growth rates in vitro and in vivo. Furthermore, the enhanced growth rates resulting from SdhB suppression are inhibited by the suppression of HIF-1alpha and/or HIF-2alpha, indicating that the mechanism of SdhB-induced tumor formation relies upon ROS production and subsequent HIF-alpha activation. Therefore, differences in ROS production, HIF proliferation, and cell proliferation contribute to the differences in tumor phenotype in cells lacking SdhB as opposed to those lacking SdhA.
Overview
CoChat Summary
TL;DR
In multiple tumor cell lines and xenografts, suppressing the distal complex II subunit SdhB increased normoxic ROS and HIF-1α/HIF-2α stabilization, enhanced proliferation and tumor growth, whereas suppressing proximal SdhA did not increase ROS/HIF and reduced growth. The SdhB-driven growth phenotype required HIF-1α and/or HIF-2α, supporting an ROS-dependent pseudohypoxic mechanism for SdhB/C/D-linked tumorigenesis.
Key findings
- Pharmacologic inhibition at SdhD with TTFA (200 µM) increased normoxic HIF-1α, HRE-luciferase activity, and ROS (roGFP, DHE, Mito-SOX); SdhA inhibitors 3-NPA (100 µM) and MMA (1 mM) did not, and blocked TTFA-induced HIF-1α stabilization.
- Stable SdhB shRNA in 143B, A549, and Hep3B cells reduced complex II activity and increased normoxic HIF-1α/HIF-2α, VEGF mRNA, HRE-luciferase, and ROS; HIF stabilization was attenuated by ebselen (25 µM), Mito-Q (1 µM), or 3-NPA (100 µM).
- SdhA shRNA reduced complex II activity but did not significantly increase normoxic HIF-1α or ROS and decreased in vitro growth; SdhB shRNA increased in vitro growth and xenograft tumor growth/mass, while SdhA shRNA tumors grew more slowly than wild-type or SdhB shRNA tumors.
- In SdhB shRNA 143B cells, suppressing HIF-1α and/or HIF-2α significantly decreased in vitro growth, tumor growth, and tumor mass compared with dHIF control.
Methods
- Used Hep3B, A549, and 143B cells with stable shRNA against SdhB or SdhA, plus retroviral HIF-1α/HIF-2α shRNA in SdhB shRNA 143B cells; pharmacologic agents included TTFA, 3-NPA, MA, MMA, DMS, ebselen, Mito-Q, and TBAP.
- Measured complex II activity, HIF-1α/HIF-2α/VEGF by immunoblot, HRE-luciferase, ROS by roGFP, DHE, and Mito-SOX, in vitro growth, and nude mouse xenografts (1 × 10⁶ cells; monitored 25–35 days).
- Compared results to wild-type/mock controls; densitometry and P < 0.05 significance were used.
Limitations
- The paper states it cannot rule out that HIF accumulation with SdhD deficiency proceeds by a different mechanism than SdhB suppression, and that the results do not refute ROS production at SdhD via SdhB/C/D mutations.
- The paper notes the H₂O₂-mediated succinate accumulation model is not inconsistent, but required high H₂O₂ (100–500 µM) and it is unclear whether such levels occur in mitochondria.
- Evident from the text: findings rely on shRNA knockdown and pharmacologic inhibitors in three cell lines rather than patient-derived Sdh mutations, and no direct succinate measurements are reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
12 Valid · 0 Not valid · 22 Not checked · 84 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We previously reported that mitochondrial reactive oxygen species (ROS) signals arising from complex III trigger HIF-1 𝛂 stabilization during hypoxia (10, 21, 31).”
What the sources say
- Partly supportedcites [10] 10. Chandel, N. S., E. Maltepe, E. Goldwasser, C. E. Mathieu, M. C. Simon, and P. T. Schumacker. 1998. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95: 11715-11720. sourceExperimental — accuracy not yet measured
Our copy of Chandel et al. (1998) supports the mitochondrial/complex III part: 'Our results show that ROS generation at complex III is required for the induction of HIF-1 DNA binding activity during hypoxia' (Results and Discussion), and 'mitochondrial complex III acts as a principal site of ROS generation during hypoxia.' However, the endpoint the paper demonstrates is HIF-1 DNA-binding activity (gel shift) and downstream EPO/VEFG/glycolytic mRNA, not HIF-1α protein stabilization — the paper attributes stabilization to others ('hypoxic stabilization of the HIF-1 complex is related to the O2 concentration (31)', and Caro and Salceda (28) for lactacystin-induced stabilization). The claim's causal 'trigger' also outruns the paper's explicit hedge: 'Our model proposes only that ROS are required for the hypoxic activation of HIF-1, but it is not yet clear whether ROS are sufficient,' with ROS generators (antimycin, menadione) failing to elicit HIF-1 stabilization during normoxia. (LLM, conf=0.78)
- Not checked yetcites [21] 21. Guzy, R. D., B. Hoyos, E. Robin, H. Chen, L. Liu, K. D. Mansfield, M. C. Simon, U. Hammerling, and P. T. Schumacker. 2005. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1: 401-408. source
- Not checked yetcites [31] 31. Mansfield, K. D., R. D. Guzy, Y. Pan, R. M. Young, T. P. Cash, P. T. Schumacker, and M. C. Simon. 2005. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF𝛂 activation. Cell Metab. 1: 393-399. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“An impairment in the normal removal of electrons from the flavin group in SdhA could promote superoxide generation through the autoxidation of the reduced flavin group by O 2 in the matrix (34, 38, 46, 51).”
What the sources say
- Partly supportedcites [34] 34. Messner, K. R., and J. A. Imlay. 2002. Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase. J. Biol. Chem. 277: 42563-42571. sourceExperimental — accuracy not yet measured
Our copy supports the mechanistic core: the flavin is the autoxidizing site in Sdh/Frd ('Flavin as the Site of Autoxidation'), Sdh 'makes only O2.-, and no H2O2, upon flavin autoxidation' (Succinate Dehydrogenase Makes Only Superoxide..., Fig. 9), and 'the relative preference of electrons to sit on the flavin is a major determinant of their tendency to autoxidize,' with Sdh's cofactor potentials 'arranged to withdraw electrons away from the flavin,' which 'may largely explain its comparatively low rate of autoxidation' — i.e. electrons retained on the flavin raise superoxide formation. Not supported by this paper: the specific counterfactual about an 'impairment in the normal removal of electrons from the flavin group in SdhA' (our copy names Sdh/FrdA mutants such as FrdA H44C and FrdB C62S, never an SdhA lesion), and the mitochondrial 'matrix' location — the work was done in E. coli inverted membrane vesicles with no reference to a matrix. (LLM, conf=0.75)
- Partly supportedcites [38] 38. Rustin, P., and A. Roetig. 2002. Inborn errors of complex II-unusual human mitochondrial diseases. Biochim. Biophys. Acta Bio-Energetics 1553: 117122. sourceExperimental — accuracy not yet measured
The Fig. 2 legend embedded in Section 3 ('Mutations in SDH B encoding the Ip subunit') does support the core idea for the SDH (Fp/Ip) subunits, including SdhA: 'some particular mutation could still favor an over-reduction of a given SDH component (e.g. flavin), resulting in superoxide production', and Section 5 adds that CII (SDH?) 'is a privileged location for superoxide production'. However, our copy nowhere states the specific mechanism the claim attributes — autoxidation of the reduced flavin by O2 — nor localises it to the matrix side (Fig. 1's legend only describes semi-quinone feeding electrons to the UQ pool). Searches for 'autoxidation', 'reduced flavin + O2' and 'matrix' returned no supporting passage, so the mechanistic detail likely rests on the sentence's other citations (34, 38, 46, 51) rather than this paper. (LLM, conf=0.72)
- Partly supportedcites [46] 46. Senoo-Matsuda, N., K. Yasuda, M. Tsuda, T. Ohkubo, S. Yoshimura, H. Nakazawa, P. S. Hartman, and N. Ishii. 2001. A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J. Biol. Chem. 276: 41553-41558. sourceExperimental — accuracy not yet measured
Our copy supports the general premise — that impaired electron flow through complex II can raise superoxide production — with the DISCUSSION passage speculating that 'the complex II defect could affect electron flow such that there is a probable increase of electrons leaking directly from complex II to molecular oxygen,' and the Abstract identifying SDHA/Fp as the flavoprotein subunit. However, the paper never attributes superoxide generation to autoxidation of the reduced flavin group of SdhA by matrix O2; its specific proposed mechanism is premature release of semiquinone at the ubiquinone-binding site of Cyt-1/ceSDHC (residue 71, the mev-1 mutation), DISCUSSION. The flavin-autoxidation element of the claim is therefore absent from this source. (LLM, conf=0.72)
- Not checked yetcites [51] 51. Yankovskaya, V., R. Horsefield, S. Toernroth, C. Luna-Chavez, H. Miyoshi, C. Leger, B. Byrne, G. Cecchini, and S. Iwata. 2003. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 299: 700-704. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Complex II oxidizes succinate to fumarate and transfers the electrons to ubiquinone through a sequence of steps involving a flavin moiety in SdhA, a set of iron-sulfur clusters in SdhB, a heme group in SdhC, and the ubiquinone binding site in SdhC and SdhD (Fig. 1) (1, 9).”
What the sources say
- Partly supportedcites [1] 1. Ackrell, B. A. C. 2000. Progress in understanding structure-function relationships in respiratory chain complex II. FEBS Lett. 466: 1-5. sourceExperimental — accuracy not yet measured
The Introduction says complex II oxidizes succinate to fumarate and transfers electrons to ubiquinone; it also places FAD in the flavoprotein, three iron–sulfur clusters in the iron–sulfur subunit, and quinone-binding sites in the membrane anchors. Sections 3 and 4 describe electron transfer from FAD through the clusters to bound quinone, but do not place heme in that transfer sequence. Section 4 describes heme as coordinated by anchor helices and emphasizes its role in assembly, so the claim that electrons pass through a heme in SdhC is not supported. (LLM, conf=0.88)
- Not checked yetcites [9] 9. Cecchini, G. 2003. Function and structure of complex II of the respiratory chain. Annu. Rev. Biochem. 72: 77-109. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, mutations in subunit SdhB, SdhC, or SdhD are linked to tumorigenesis in the form of autosome-dominant familial paragangliomas and pheochromocytomas (1, 3, 16, 19, 33).”
What the sources say
- Could not verifycites [1] 1. Ackrell, B. A. C. 2000. Progress in understanding structure-function relationships in respiratory chain complex II. FEBS Lett. 466: 1-5. sourceExperimental — accuracy not yet measured
The Introduction discusses mutated respiratory-chain complex II in nematodes, and §2 (Flavoprotein subunit) describes a human mutation causing complex II deficiency. Neither passage addresses SDHB, SDHC, or SDHD mutations in familial paragangliomas or pheochromocytomas; searches for those tumors and for familial SDH mutations found no relevant passage. Page numbers were not available in our copy. (LLM, conf=0.75)
- Not checked yetcites [3] 3. Baysal, B. E., R. E. Ferrell, J. E. Willett-Brozick, E. C. Lawrence, D. Myssiorek, A. Bosch, A. van der Mey, P. E. Taschner, W. S. Rubinstein, E. N. Myers, C. W. Richard III, C. J. Cornelisse, P. Devilee, and B. Devlin. 2000. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848-851. source
- Not checked yetcites [16] 16. Douwes Dekker, P. B. D., P. C. W. Hogendoorn, N. Kuipers-Dijkshoorn, F. A. Prins, S. G. Van Duinen, P. E. M. Taschner, A. G. L. Van der Mey, and C. J. Cornelisse. 2003. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J. Pathol. 201: 480-486. source
- Supportedcites [19] 19. Gimenez-Roqueplo, A. P., J. Favier, P. Rustin, J. J. Mourad, P. F. Plouin, P. Corvol, A. Roetig, and X. Jeunemaitre. 2001. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am. J. Hum. Genet. 69: 1186-1197. source
The Discussion identifies SDHD, SDHC, and SDHB mutations as responsible for familial paraganglioma and describes its inheritance as usually autosomal dominant. The Introduction reports familial pheochromocytoma associated with SDHD and SDHB mutations; the paper's own family had an SDHD mutation and both tumor types. Page numbers were not provided in our copy. (LLM, conf=0.91)
- Partly supportedcites [33] 33. McWhinney, S. R., R. T. Pilarski, S. R. Forrester, M. C. Schneider, M. M. Sarquis, E. P. Dias, and C. Eng. 2004. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J. Clin. Endocrinol. Metab. 89: 5694-5699. sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) says germline mutations in SDHB, SDHC, and SDHD cause hereditary pheochromocytoma/paraganglioma syndrome, supporting the link to familial tumors. Our copy explicitly calls SDHC-associated paraganglioma autosomal dominant in a reference title, but does not establish that inheritance pattern for all three genes; the Discussion (page unavailable) also notes maternal imprinting in SDHD-associated disease. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Other studies with diverse model systems also indicate that mutations in complex II can cause increases in ROS production (24, 25, 46, 51, 54).”
What the sources say
- Not checked yetcites [24] 24. Ishiguro, H., K. Yasuda, N. Ishii, K. Ihara, T. Ohkubo, M. Hiyoshi, K. Ono, N. Senoo-Matsuda, O. Shinohara, F. Yosshii, M. Murakami, P. S. Hartman, and M. Tsuda. 2001. Enhancement of oxidative damage to cultured cells and Caenorhabditis elegans by mitochondrial electron transport inhibitors. IUBMB Life 51: 263-268. source
- Not checked yetcites [25] 25. Ishii, N., M. Fujii, P. S. Hartman, M. Tsuda, K. Yasuda, N. Senoo-Matsuda, S. Yanase, D. Ayusawa, and K. Suzuki. 1998. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 394: 694-697. source
- Supportedcites [46] 46. Senoo-Matsuda, N., K. Yasuda, M. Tsuda, T. Ohkubo, S. Yoshimura, H. Nakazawa, P. S. Hartman, and N. Ishii. 2001. A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J. Biol. Chem. 276: 41553-41558. source
Our copy directly demonstrates the attributed point: the Results section 'Production of Superoxide Anion from Mitochondria Is Elevated in mev-1 Mutants' reports ~2-fold higher superoxide production in mitochondria and SMP from mev-1 animals (which carry a missense mutation in Cyt-1/ceSDHC, the complex II cytochrome b large subunit) versus wild type, and the Discussion summary states mev-1 animals manifest 'superoxide anion overproduction from mitochondrial complex II itself... by the mutation in Cyt-1/ceSDHC subunit.' The hedged 'can cause' in the citing sentence matches the source's claim, and the paper's caveat that the effect is allele-specific (residue 71 missense; more severe mutations may not elevate superoxide) does not contradict a possibility-level statement. The one organism studied (C. elegans) is not overstated by the citing sentence, which pools this with other model systems. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
65 more claims · 2 with their cited sources checked
Create a free account to see all 118 claims and to verify the 43 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 40
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This requires both succinate oxidation by the enzyme succinate dehydrogenase (SDH) and an increase in mitochondrial membrane potential.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has also been reported that defects in SDH B increase ROS production and that ROS enhance the stabilization of HIFα produced by succinate accumulation (Guzy et al., 2007), although the importance of ROS in this setting has been disputed (Lee et al., 2005; Selak et al., 2006).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Guzy et al., 2007
The cited source says what the claim attributes to it.
In the citing paper
“Accumulation of reactive oxygen species, an independent trigger for HIF stabilization, may contribute to this process in some cases of defective SDH or FH (Guzy et al., 2008; Sudarshan et al., 2009).”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Guzy et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ MATERIALS AND METHODS
“For dihydroethidium (DHE) and Mito-SOX experiments, cells were treated with the appropriate conditions for 5 to 6 h before the addition of DHE (10 𝛍 M) or Mito-SOX (1 𝛍 M) to the culture medium. Cells were incubated for an additional 1.5 h”
§ RESULTS
“After treatment for 5 h, DHE (1 𝛍 M) was added for an additional hour.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ RESULTS
“either polyclonal (SdhA clone 3) or monoclonal (SdhA clones 3C and 3L)”
§ RESULTS
“a monoclonal SdhA shRNA line (SdhA polyclonal line 3C)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ MATERIALS AND METHODS
“Cells were incubated for an additional 1.5 h before being trypsinized and resuspended.”
§ RESULTS
“(H) Cells were treated with the indicated compounds for 5 h, after which Mito-SOX (1 𝛍 M) was added for an additional hour.”
Citations
Cites
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 7×
“In a previous study, the suppression of SdhD expression led to an increase in HIF-1 stabilization, a response that was attributed to the inhibition of PHD by succinate that accumulated as a consequence of the impairment in complex II activity ( 43 ).”
BackgroundMethodInfluentialOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068 · cited 1×
“A similar model of substrate-mediated PHD inhibition has been described (23, 37, 42) in which the loss of fumarate hydratase activity leads to the accumulation of fumarate, which also can inhibit PHD competitively.”
BackgroundChandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Self-citationMitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 2×
“Previous studies have implicated complex III in the cellular O2-sensing pathway involved in the regulation of HIF- stability during hypoxia (10, 21).”
BackgroundSelf-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“However, mutations in subunit SdhB, SdhC, or SdhD are linked to tumorigenesis in the form of autosome-dominant familial paragangliomas and pheochromocytomas (1, 3, 16, 19, 33).”
BackgroundMitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545
Self-citationUbisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria
Turrens, J. F., Alexandre, A., & Lehninger, A. L. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90293-0 · Cited by 1,214 · cited 1×
“Those interventions would be expected to increase cytosolic superoxide levels, because AA generates superoxide at the outer surface of the inner mitochondrial membrane (50) while p53 induces the expression of a variety of nonmitochondrial oxidase systems (53).”
BackgroundHanson, G. T., Aggeler, R., Oglesbee, D., Cannon, M., Capaldi, R. A., Tsien, R. Y., & Remington, S. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312846200 · Cited by 988 · cited 1×
“Using a novel, engineered, ratiometric fluorescent protein redox sensor (roGFP) (15, 22) expressed in cells by using a recombinant adenovirus, we find that the acute administration of TTFA significantly increases the rate of protein thiol oxidation compared to that induced by 3-NPA, MMA (Fig.”
BackgroundIsaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958 · cited 1×
“A similar model of substrate-mediated PHD inhibition has been described ( 23 , 37, 42) in which the loss of fumarate hydratase activity leads to the accumulation of fumarate, which also can inhibit PHD competitively.”
BackgroundArchitecture of succinate dehydrogenase and reactive oxygen species generation
Yankovskaya, V., Horsefield, R., Törnroth, S., Luna-Chavez, C., Miyoshi, H., Léger, C., Byrne, B., Cecchini, G., & Iwata, S. (2003) · Science · doi:10.1126/science.1079605 · Cited by 927 · cited 5×
“... II oxidizes succinate to fumarate and transfers the electrons to ubiquinone through a sequence of steps involving a flavin moiety in SdhA, a set of iron-sulfur clusters in SdhB, a heme group in SdhC, and the ubiquinone binding site in SdhC and SdhD (Fig. 1) (1, 9). When complex II is disrupted at SdhB, SdhC, or Sd…”
BackgroundInfluential
Cited by
Items 201–300 of 426
Salem, A. F., Howell, A., Sartini, M., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.22316 · Cited by 45
Succinate at the Crossroad of Metabolism and Angiogenesis: Roles of SDH, HIF1α and SUCNR1
Atallah, R., Olschewski, A., & Heinemann, Á. (2022) · Biomedicines · doi:10.3390/biomedicines10123089 · Cited by 47
“showed that antioxidants abolished the effects of succinate on HIF1 activation [101].”
BackgroundMolecular markers of paragangliomas/pheochromocytomas
Zhikrivetskaya, S. O., Snezhkina, A. V., Zaretsky, A. R., Alekseev, B. Y., Pokrovsky, A. V., Golovyuk, A. L., Melnikova, N. V., Stepanov, O. A., Kalinin, D. V., Moskalev, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15201 · Cited by 45
“The ROS level is elevated in cells with mutant FH [101], whereas data on ROS concentration in SDH-mutant cells are contradictory [95, 102-104].”
BackgroundZhou, Z., Ibekwe, E., & Chornenkyy, Y. (2018) · Antioxidants · doi:10.3390/antiox7010016 · Cited by 45
“Using hepatoblastoma 3G (Hep3G) or hepatocellular carcinoma 3B (Hep3B) cells, lung carcinoma (A549) cells, and osteosarcoma cells, Guzy and colleagues demonstrated that RNA knockdown and pharmacologic inhibition of SDH-B, but not SDH-A, produced increased levels of ROS, HIF activation, and tumorigenesis [121].”
BackgroundFletcher, S. C., & Coleman, M. L. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190333 · Cited by 55
Richter, S., Qin, N., Pacak, K., & Eisenhofer, G. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-411512-5.00014-2 · Cited by 42
Yebra, M., Bhargava, S., Kumar, A., Burgoyne, A. M., Tang, C.-M., Yoon, H., Banerjee, S., Aguilera, J., Cordes, T., Sheth, V. R., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2092 · Cited by 43
MiR-31/SDHA Axis Regulates Reprogramming Efficiency through Mitochondrial Metabolism
Lee, M. R., Mantel, C., Lee, S. A., Moon, S., & Broxmeyer, H. E. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.05.012 · Cited by 41
“…inhibition of SDHA does not increase production of ROS under conditions of normal O2 tension (normoxia), suggesting that reduction of SDHA activity might be an ideal way to reduce mitochondrial ETC activity, thus promoting fulliPSC induction while maintaining low ROS generation (Guzy et al., 2008).”
BackgroundParanagama, M. P., Sakamoto, K., Amino, H., Awano, M., Miyoshi, H., & Kita, K. (2010) · Mitochondrion · doi:10.1016/j.mito.2009.12.145 · Cited by 40
NF-κB mediates aberrant activation of HIF-1 in malignant lymphoma
Qiao, Q., Nozaki, Y., Sakoe, K., Komatsu, N., & Kirito, K. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.08.007 · Cited by 44
“In addition to these mechanisms, we cannot exclude the possibility that HIF-1a protein stability was also increased through pseudohypoxia caused by mutation of succinate dehydrogenase, resulting in the accumulation of succinate, which blocks HIF-1a prolyl-hydroxylase [25,26].”
BackgroundPowerhouse down: Complex II dissociation in the respiratory chain
Hwang, M., Rohlena, J., Dong, L., Neužil, J., & Grimm, S. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.06.001 · Cited by 44
Succinate Dehydrogenase Upregulation Destabilize Complex I and Limits the Lifespan of gas-1 Mutant
Pujol, C., Bratic-Hench, I., Sumakovic, M., Hench, J., Mourier, A., Baumann, L., Pavlenko, V., & Trifunovic, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059493 · Cited by 39
New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma
Taïeb, D., & Pacák, K. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.08.001 · Cited by 43
Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
Trejo‐Solís, C., Castillo‐Rodríguez, R. A., Serrano-García, N., Silva‐Adaya, D., Vargas-Cruz, S., Chávez-Cortéz, E. G., Gallardo‐Pérez, J. C., Zavala-Vega, S., Cruz-Salgado, A., & Magaña-Maldonado, R. (2024) · Metabolites · doi:10.3390/metabo14050249 · Cited by 42
“…of prolyl dehydrogenase, resulting in succinate accumulation, or indirectly by ROS generation due to a defect in mitochondrial complex II [181,250]. miR-448 has been shown to inhibit proliferation, migration, and invasion while increasing radiosensitivity in vitro and in vivo in glioma cells.”
BackgroundShankavaram, U. T., Fliedner, S. M. J., ELKAHLOUN, A. G., Barb, J. J., Munson, P. J., Huynh, T., Matro, J. C., Turková, H., Linehan, W. M., Timmers, H. J. L. M., et al. (2013) · Neoplasia · doi:10.1593/neo.122132 · Cited by 42
Renal cell carcinoma: translational aspects of metabolism and therapeutic consequences
Yang, O. C. Y., Maxwell, P. H., & Pollard, P. J. (2013) · Kidney International · doi:10.1038/ki.2013.245 · Cited by 41
Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma
Liu, Y., Pang, Y. K., Caisová, V., Ding, J., Yu, D., Zhou, Y., Huynh, T., Ghayee, H. K., Pacák, K., & Yang, C. (2020) · Cancers · doi:10.3390/cancers12020280 · Cited by 42
“Moreover, the loss of the SDHB subunit prompts the accumulation of electrons in the flavin group in SDHA, which promotes superoxide generation through the autoxidation of the reduced flavin group by O2 in the matrix [25].”
BackgroundEpigenetic and metabolic reprogramming of SDH-deficient paragangliomas
Moog, S., Lussey‐Lepoutre, C., & Favier, J. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0346 · Cited by 45
Succinate in innate immunity: linking metabolic reprogramming to immune modulation
Atallah, R., Gindlhuber, J., & Heinemann, Á. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1661948 · Cited by 48
Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma
Vícha, A., Taïeb, D., & Pacák, K. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0398 · Cited by 37
“ROS exposure also inhibits the interaction of HIFa and PHDs, similar to the accumulation of succinate, but it is proposed that such an inhibition of this interaction by ROS may be more important for tumorigenesis (Yankovskaya et al. 2003, Guzy et al. 2008, Majmundar et al. 2010).”
Molecular pathogenesis of tumorigenesis caused by succinate dehydrogenase defect
Moosavi, B., Zhu, X., Yang, W., & Yang, G. (2019) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2019.151057 · Cited by 38
Hu, X., & Zhang, L. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.011 · Cited by 40
dos Santos, P. L., Pimenta, T., & Taveira‐Gomes, A. (2014) · International Journal of Surgical Pathology · doi:10.1177/1066896914537683 · Cited by 37
Fliedner, S. M. J., Kaludercic, N., Jiang, X.-S., Hansíková, H., Hájková, Z., Sládková, J., Limpuangthip, A., Backlund, P. S., WESLEY, R. A., Martiniova, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040949 · Cited by 36
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
Duraj, T., Carrión-Navarro, J., Seyfried, T. N., Garcia‐Romero, N., & Ayuso‐Sacido, Á. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101389 · Cited by 42
“Metabolic reprogramming enables proliferation despite varying degrees of mitochondrial dysfunction [55 e 57].”
Kondrashova, M. N., Zakharchenko, M. V., & Khunderyakova, N. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.04.020 · Cited by 41
Konieczna, A., Szczepańska, A., Sawiuk, K., Węgrzyn, G., & Łyżeń, R. (2015) · BMC Cell Biology · doi:10.1186/s12860-015-0062-8 · Cited by 33
“Silencing of expression of the SDHA gene resulted in a decrease of growth rate of cancer cells [24].”
Saito, Y., Ishii, K., Aita, Y., Ikeda, T., Kawakami, Y., Shimano, H., Hara, H., & Takekoshi, K. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1738-3 · Cited by 39
“The first hypothesis states that redox stress results from increased mitochondrial reactive oxygen species (ROS) production [13].”
BackgroundInfluentialOxygen Concentration Controls Epigenetic Effects in Models of Familial Paraganglioma
Her, Y. F., Nelson-Holte, M. H., & Maher, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127471 · Cited by 35
Hypoxia-inducible C-to-U coding RNA editing downregulates SDHB in monocytes
Baysal, B., Jong, K. D., Liu, B., Wang, J., Patnaik, S., Wallace, P., & Taggart, R. (2013) · PeerJ · doi:10.7717/peerj.152 · Cited by 27
“Succinate and reactive oxygen species that accumulate upon SDH inactivation were implicated as downstream messengers leading to stabilization of HIF1α in normoxic conditions (Selak et al., 2005; Guzy et al., 2008).”
BackgroundThe Warburg Phenomenon and Other Metabolic Alterations of Cancer Cells
Dakubo, G. D. (2010) · Springer eBooks · doi:10.1007/978-3-642-11416-8_2 · Cited by 41
“Consistent with this suggestion, ROS from complexes II and III have both been implicated in HIF1a stabilization (Guzy et al. 2005, 2008; Klimova and Chandel 2008).”
BackgroundWang, H., Luo, J., Tian, W., Yan, W., Ge, S., Zhang, Y., & Sun, W. (2019) · Toxicology · doi:10.1016/j.tox.2019.01.018 · Cited by 33
Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria
Ploeger, C., Huth, T., Sugiyanto, R. N., Pusch, S., Goeppert, B. F., Singer, S., Tabti, R., Haußer, I., Schirmacher, P., Désaubry, L., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03220-3 · Cited by 34
Stretch-Induced Activation of AMP Kinase in the Lung Requires Dystroglycan
Budinger, G. R. S., Urich, D., DeBiase, P. J., Chiarella, S. E., Burgess, Z., Baker, C. M., Soberanes, S., Mutlu, G. M., & Jones, J. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0432oc · Cited by 31
“The oxidation state of the cells was calculated as the completely reduced ration (DTT) less the untreated value divided by the difference in the ration observed with DTT and t-butyl hydroperoxide (17).”
MethodVerma, M., Kipari, T. M. J., Zhang, Z., Man, T. Y., Forster, T., Homer, N. Z. M., Seckl, J. R., Holmes, M. C., & Chapman, K. E. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.015 · Cited by 34
“Increased SDH/complex II activity might reduce ROS damage during systemic inflammation (Chouchani et al., 2014; Guzy et al., 2008).”
BackgroundBayley, J., Bausch, B., Rijken, J. A., van Hulsteijn, L. T., Jansen, J. C., Ascher, D. B., Pires, D. E. V., Hes, F. J., Hensen, E. F., Corssmit, E. P. M., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106214 · Cited by 33
Systemic ablation of vitamin D receptor leads to skeletal muscle glycogen storage disorder in mice
Das, A., Gopinath, S. D., & Arimbasseri, G. A. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12841 · Cited by 30
“Interestingly, reduced levels of SDHA, but not SDHB, are known to be associated with reduced OXPHOS.(33) Apart from the mitochondrial proteins imported from cytoplasm, the mitochondrial genome expresses 13 proteins that are essential functional components of all ETC and ATP synthase complexes.”
BackgroundLv, W.-H., Zhao, T., Pantopoulos, K., Chen, G., Wei, X., Zhang, D.-G., & Luo, Z. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0190 · Cited by 32
“In this study, Mn reduced the expression of sod2 , cat, and sdhb mRNAs, as well as the protein levels of SOD2 and SDHB. Guzy et al. (15) pointed out that the inhibition of the SdhB increases normoxic ROS production.”
Todisco, S., Musio, B., Pesce, V., Cavalluzzi, M. M., Petrosillo, G., Piana, G. L., Sgobba, M. N., Schlosserová, N., Beltrame, L. C., Lorenzo, R. D., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115405 · Cited by 32
Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison
Chong, S. J. F., Lai, J. X. H., Eu, J. Q., Bellot, G. L., & Pervaiz, S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7441 · Cited by 30
“- at the mitochondria (23, 34, 35, 96, 111, 205).”
Succinate as a signaling molecule in the mediation of liver diseases
Chen, H., Jin, C., Xie, L. H., & Wu, J. H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166935 · Cited by 38
The flux of energy in critical illness and the obesity paradox
Jaitovich, A., & Hall, J. B. (2025) · Physiological Reviews · doi:10.1152/physrev.00029.2024 · Cited by 37
Role of gp130 in basal and exercise-trained skeletal muscle mitochondrial quality control
Fix, D. K., Hardee, J. P., Gao, S., VanderVeen, B. N., Velázquez, K. T., & Carson, J. A. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01063.2017 · Cited by 35
“The iron-sulfur subunit of this complex (SDHB) is responsible for the removal of the electrons from SDHA and the transfer to ubiquinone.”
BackgroundInfluentialImproving coenzyme Q10 yield of Rhodobacter sphaeroides via modifying redox respiration chain
Zhang, J., Gao, D., Cai, J., Liu, H., & Qi, Z. (2018) · Biochemical Engineering Journal · doi:10.1016/j.bej.2018.04.006 · Cited by 30
Richter, S., D’Antongiovanni, V., Martinelli, S., Bechmann, N., Riverso, M., Poitz, D. M., Pacák, K., Eisenhofer, G., Mannelli, M., & Rapizzi, E. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2907-x · Cited by 32
Sirtuin 3 Deficiency Does Not Augment Hypoxia-Induced Pulmonary Hypertension
Waypa, G. B., Osborne, S. W., Marks, J. D., Berkelhamer, S. K., Kondapalli, J., & Schumacker, P. T. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0191oc · Cited by 33
Self-citationModels of parent-of-origin tumorigenesis in hereditary paraganglioma
Hoekstra, A. S., Devilee, P., & Bayley, J. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.05.011 · Cited by 35
The versatile biochemistry of iron in macrophage effector functions
Behmoaras, J. V. (2021) · FEBS Journal · doi:10.1111/febs.15682 · Cited by 32
The pattern of natural selection in somatic cancer mutations of human mtDNA
Stafford, P., & Chen-Quin, E. B. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.76 · Cited by 30
Markevich, N. I., Galimova, M. H., & Markevich, L. N. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101630 · Cited by 27
Oxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration
Quaegebeur, A., & Carmeliet, P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_83 · Cited by 33
“Arguably, a dysfunctional electron transport could increase ROS generation, representing another mechanism of HIF upregulation (Guzy et al. 2008).”
BackgroundThiol‐based redox proteomics in cancer research
Yuan, K., Liu, Y., Chen, H., Zhang, L., Lan, J., Gao, W. Q., Dou, Q., Nice, E. C., & Huang, C. (2014) · PROTEOMICS · doi:10.1002/pmic.201400164 · Cited by 35
Luft, J. G., Reinhardt, L. S., Morás, A. M., da Rosa, M. S., Leipnitz, G., Regner, G. G., Pflüger, P., Gonçalves, D. A., Moura, D. J., & Pereira, P. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01675-6 · Cited by 31
Targeting succinate:ubiquinone reductase potentiates the efficacy of anticancer therapy
Kruspig, B., Valter, K., Skender, B., Zhivotovsky, B., & Gogvadze, V. G. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.04.026 · Cited by 27
Succinate mediates inflammation-induced adrenocortical dysfunction
Mateska, I., Witt, A., Hagag, E., Sinha, A. N., Yılmaz, C., Thanou, E., Sun, N., Kolliniati, O., Patschin, M., Abdelmegeed, H., et al. (2023) · eLife · doi:10.7554/elife.83064 · Cited by 28
Guo, S., Cheng, X., Lim, J.-H., Liu, Y., & Kao, H. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-11-0692 · Cited by 29
“Although complex II has not generally been considered a major source of mitochondrial ROS, emerging evidence has demonstrated its indispensable role in ROS production (Paddenberg et al., 2003; Calkins et al., 2005; Ishii et al., 2005; Guzy et al., 2008).”
BackgroundBezawork‐Geleta, A., Dong, L., Rohlena, J., & Neužil, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.c116.755017 · Cited by 27
“SDH activity was assessed using isolated mitochondria (11, 44).”
BackgroundMethodInfluentialHe, C., Chen, P., Li, N., Huang, X., Sun, H., Wang, Y., Zhao, Y., Zeng, C., Huang, D., Gao, H., et al. (2025) · Inflammation · doi:10.1007/s10753-024-02207-y · Cited by 27
“Inhibition of SDHB through small molecules or SDHB knockdown enhance ROS production and promote stabilization of HIF-α [38].”
Mattox, T. A., Young, M. E., Rubel, C. E., Spaniel, C., Rodriguez, J., Grevengoed, T. J., Gautel, M., Xu, Z., Anderson, E. J., & Willis, M. S. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9549-9 · Cited by 26
Oh, J., & Moon, E. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.07.002 · Cited by 28
Zhang, L., Qiu, L., Xu, S., Cheng, X. F., Wu, J., Wang, Y., Gao, W., Bao, J., & Yu, H. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105669 · Cited by 26
von Arx, C., Capozzi, M., López-Jiménez, E., Ottaiano, A., Tatangelo, F., Di Mauro, A., Nasti, G., Tornesello, M. L., & Tafuto, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091277 · Cited by 24
Yang, Q., Cai, Y., Ma, Q., Xiong, A., Xu, P., Zhang, Z., Xu, J., Zhou, Y., Liu, Z., Zhao, D., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk3868 · Cited by 24
“Many studies have shown that succinate accumulation stabilizes HIF ( 44, 45 ).”
BackgroundPortier, L., Desterke, C., Chaker, D., Oudrhiri, N., Asgarova, A., Dkhissi, F., Turhan, A. G., Griscelli, A. B., & Griscelli, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031227 · Cited by 25
“This in turn led to the stabilization of HIF-1α and to an increase in the half-life of this protein [24].”
BackgroundGenetically Modeled Mice with Mutations in Mitochondrial Metabolic Enzymes for the Study of Cancer
Piruat, J. I., & Millán‐Uclés, Á. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00200 · Cited by 23
“For instance, several groups have proposed that in SDH-deficient cultured cells an increase in the levels of ROS occurs likely due to electron leakage from the MCII and/or perhaps a biased accumulation of the semi reduced form of ubiquinone (74, 75).”
BackgroundPaddenberg, R., Tiefenbach, M., Faulhammer, P., Goldenberg, A., Gries, B., Pfeil, U., Lips, K. S., Piruat, J. I., López‐Barneo, J., SCHERMULY, R. T., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr359 · Cited by 22
An Assembly Factor Promotes Assembly of Flavinated SDH1 into the Succinate Dehydrogenase Complex
Belt, K., Aken, O. V., Murcha, M. W., Millar, A. H., & Huang, S. (2018) · PLANT PHYSIOLOGY · doi:10.1104/pp.18.00320 · Cited by 23
“Studies in mammalian cells also showed that knockdown of SDH2, but not SDH1, caused an increase in ROS production (Ishii et al., 1998; Guzy et al., 2008).”
BackgroundKamarauskaitė, J., Banienė, R., Trumbeckas, D., Strazdauskas, A., & Trumbeckaitė, S. (2021) · Antioxidants · doi:10.3390/antiox10050747 · Cited by 24
SDH defective cancers: molecular mechanisms and treatment strategies
Wang, J., Yuan, T., Yang, B. W., He, Q., & Zhu, H. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10022-w · Cited by 32
“Additionally, other studies indicate that mutations in SDHB, SDHC, or SDHD subunits affect superoxide generation at the ubiquinone binding site in SDHD through intermolecular interactions (Guzy et al. 2008).”
Hypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets
Kling, L., Schreiber, A., Eckardt, K., & Kettritz, R. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ri0820-535r · Cited by 25
SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma
Bayley, J., Bausch, B., Jansen, J. C., Hensen, E. F., van der Tuin, K., Corssmit, E. P. M., Devilee, P., & Neumann, H. P. H. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107656 · Cited by 24
Grayson, C., & Mailloux, R. J. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.08.015 · Cited by 25
Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus
Tumurkhuu, G., Montano, E. N., & Jefferies, C. A. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0842-9 · Cited by 22
Proteome analysis of Bemisia tabaci suggests specific targets for RNAi mediated control
Mishra, M., Saurabh, S., Maurya, R., Mudawal, A., Parmar, D., & Singh, P. K. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.11.020 · Cited by 21
Mitochondrial metabolic remodeling in response to genetic and environmental perturbations
Hollinshead, K. E. R., & Tennant, D. A. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1334 · Cited by 24
“One of the few studies to examine the differential effects of deficiencies of different SDH subunits suggested that RNAi-mediated reduction in the expression of SDHB led to increased mitochondrial ROS production, while this was not recapitulated by similar reduction of SDHA.72 However, another study has suggested that…”
ResultFliedner, S. M. J., Brabant, G. E., & Lehnert, H. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2760-3 · Cited by 28
“Richter et al. showed a 25-fold increase of succinate level in SDHx compared to non-SDHx PGLs at unchanged 2-oxoglutarate concentration.”
BackgroundInfluentialRodent models of pheochromocytoma, parallels in rodent and human tumorigenesis
Lussey‐Lepoutre, C., Buffet, A., Morin, A., Goncalves, J., & Favier, J. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2797-y · Cited by 25
“demonstrated that targeting the hypoxic response in Sdhb knockdown cells did lead to a reduction of their growth in immunodeficient mice (Guzy et al. 2008).”
BackgroundRanganayaki, S., Jamshidi, N., Aiyaz, M., Santhoshkumar, R., Gayathri, N., Harsha, P. K., Padmanabhan, B., & Bharath, M. M. S. (2021) · Scientific Reports · doi:10.1038/s41598-020-79339-2 · Cited by 21
Saskői, É., Hujber, Z., Nyírő, G., Likó, I., Mátyási, B., Petővári, G., Mészáros, K. V., Kovács, A., Patthy, L., Supekar, S., et al. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.044925 · Cited by 20
“Third, it is suggested that dysfunctional SDHx can trigger increased levels of reactive oxygen species (ROS) with potential to damage macromolecules including DNA, proteins and lipids (Slane et al., 2006; Guzy et al., 2008; Tretter et al., 2016).”
BackgroundZakharchenko, M. V., Zakharchenko, A. V., Khunderyakova, N. V., Tutukina, M. N., Simonova, M. A., Vasilieva, A. A., Romanova, O. I., Fedotcheva, N. I., Litvinova, E. G., Maevsky, E. I., et al. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.07.003 · Cited by 26
Melatonin and its mechanism of action in the female reproductive system and related malignancies
Ezzati, M., Velaei, K., & Kheirjou, R. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04151-z · Cited by 26
“Low level of SDHB can induce succinate accumulation which lead to the advancement of UEC by voltage-gated potassium channel subfamily Q member 1 (KCNQ1) downregulation [180, 181].”
BackgroundBalnis, J., Drake, L. A., Vincent, C. E., Korponay, T. C., Singer, D. V., Lacomis, D., Lee, C. G., Elias, J. A., Jourd’heuil, D., Singer, H. A., et al. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0551oc · Cited by 19
Millán‐Uclés, Á., Castro, B. D., García‐Flores, P., Báez, A., Pérez‐Simón, J. A., López‐Barneo, J., & Piruat, J. I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085528 · Cited by 21
“Diffusion of ROS throughout the cell would eventually cause nuclear DNA damage and higher transforming mutation rates [15,17,18].”
BackgroundNengroo, M. A., Klein, A. T., Carr, H. S., Vidal-Cruchez, O., Sahu, U., McGrail, D. J., Sahni, N., Thompson, N. B., Faull, P. A., Gao, P., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.10.002 · Cited by 24
Sun, B., Yu, L., Xu, C., Li, Y., Zhao, Y., Cao, M., & Yang, L. (2021) · Cancer Science · doi:10.1111/cas.14925 · Cited by 20
Weight Loss by Ppc-1, a Novel Small Molecule Mitochondrial Uncoupler Derived from Slime Mold
Suzuki, T., Kikuchi, H., Ogura, M., Homma, M. K., Oshima, Y., & Homma, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117088 · Cited by 19
“The electron transfer system and ATP synthase are strictly regulated, through molecular interactions and intra-mitochondrial signaling systems which under various conditions can be labile, reducing ATP synthesis and producing excess reactive oxygen species [27–30].”
Konieczna, A., Szczepańska, A., Sawiuk, K., Łyżeń, R., & Węgrzyn, G. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.11.016 · Cited by 18
From Transcriptional Profiling to Tumor Biology in Pheochromocytoma and Paraganglioma
Cascón, A., & Tennant, D. A. (2012) · Endocrine Pathology · doi:10.1007/s12022-012-9195-x · Cited by 17
Vanova, K. H., Yang, C., Meuter, L., Neužil, J., & Pacák, K. (2021) · Cancers · doi:10.3390/cancers13153769 · Cited by 34
“found that SDHB inhibition (Hep3B human hepatoma cells, A549 human alveolar epithelium-derived tumor cells, and 143B human osteosarcoma cells) led to the accumulation of ROS [32], which was later confirmed by SDHB silencing in rat PHEO cells (PC12 cells) [33], mouse PHEO cells (MPC cells) [34,35], immortalized mouse c…”
BackgroundGermanova, E. L., Khmil, N. V., Pavlik, L. L., Mikheeva, I. B., Mironova, G. D., & Lukyanova, L. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214248 · Cited by 18
Thai, L. M., O’Reilly, L., Reibe, S., Sue, N., Holliday, H., Small, L., Schmitz‐Peiffer, C., Dhenni, R., Tsai, V. W.-W., Norris, N., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106477 · Cited by 16
Chang, Y.-L., Hsieh, M., Chang, W., Wang, H., Lin, M., Wang, C., Lou, P., & Teng, S. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5966 · Cited by 19
SDH2 is Involved in Proper Hypha Formation and Virulence in Candida Albicans
Bi, S., Lv, Q., Wang, T.-T., Fuchs, B. B., Hu, D., Anastassopoulou, C. G., Desalermos, A. P., Muhammed, M., Wu, C., Jiang, Y., et al. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0033 · Cited by 18
Hypothesis: Why Different Types of SDH Gene Variants Cause Divergent Tumor Phenotypes
Bayley, J., & Devilee, P. (2022) · Genes · doi:10.3390/genes13061025 · Cited by 19
“In the absence of SDHB, SDHA can still oxidize succinate [21] but likely at a much lower rate compared to assembled complex II, resulting in lower ROS levels compared to SDHB, SDHC and SDHD missense variants, which may also generate superoxide at the ubiquinone binding site [20,35] in addition to the SDHA FAD site.”
BackgroundMetabolomics in paraganglioma: applications and perspectives from genetics to therapy
Richter, S., Garrett, T. J., Bechmann, N., Clifton-Bligh, R. J., & Ghayee, H. K. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0376 · Cited by 16
Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC
Sinicropi-Yao, S. L., Amann, J. M., Lopez, D. L. Y., Cerciello, F., Coombes, K. R., & Carbone, D. P. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.10.162 · Cited by 19
“Three mitochondrial proteins SDHB, IDH2, and MRPS22 that we identified interacting in LUAD but not LUSC models are known to have key roles in cancer including effects on metabolism, HIF1A stabilization, and impairment of DNA methylation.(50-52) IDH2 is a very interesting link given that the genetic variant rs11540478…”
Dai, Z., Pan, S., Chen, C., Cao, L., Li, X., Chen, X., Su, X., & Lin, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-4107-6 · Cited by 16
“series of downstream target genes [26].”
Li, B. J., Tian, X., Wang, C., Zeng, X., Xing, Y.-M., Ling, H., Yin, W., Tian, L., Meng, Z.-X., Zhang, J., et al. (2017) · Scientific Reports · doi:10.1038/srep41283 · Cited by 16
“Dysfunction of SDH of complex II catalyzing succinate to fumarate caused succinate enrichment and ROS generation 20–22 .”
Mitochondrial complex II regulates a distinct oxygen sensing mechanism in monocytes
Sharma, S., Wang, J., Gomez, E. C., Taggart, R. T., & Baysal, B. E. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx041 · Cited by 16
Hypoxia-induced reactive oxygen species in organ and tissue fibrosis
Xie, L., WANG, Q., Ma, J., & Zeng, Y. (2022) · Biocell · doi:10.32604/biocell.2023.024738 · Cited by 15
“Inhibition of mitochondrial complex II, either pharmacologically or via RNA interference of succinate dehydrogenase complex ironsulfur subunit B, could increase ROS production and, subsequently, the ability to stabilize HIF-1α (Guzy et al., 2008).”
Background
Metadata
- Authors
- Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T.
- Affiliations
- Department of Pediatrics, Division of Neonatology
- Northwestern University (US)
- Corresponding author
- Schumacker, Paul T.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-01-01
- Volume
- 28
- Issue
- 2
- Pages
- 718-731
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2223429
- OpenAlex
- W2149282639
- Semantic Scholar
- b18b26c88fdc8fd4b5c2258a52b72d9bb98605aa
- Cited by
- 427
- References
- 54
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 20 · 2023: 29 · 2022: 18 · 2021: 30 · 2020: 31 · 2019: 22 · 2018: 26 · 2017: 18 · 2016: 23 · 2015: 24 · 2014: 32 · 2013: 22 · 2012: 29
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 32646, HL079650, R01HL035440, R01HL079650, HL35440)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- succinate dehydrogenase, SDHB, SDHA, reactive oxygen species, hypoxia-inducible factor alpha, HIF-1α, HIF-2α, tumor suppressor, carcinogenesis, cell proliferation
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Humans, Iron-Sulfur Proteins, Male, Mice, Nude, Neoplasm Transplantation, Protein Binding, Succinate Dehydrogenase, Signal Transduction, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Protein Subunits, RNA Interference, Electron Transport Complex II, Cell Line, Tumor, Cell Proliferation, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.